Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Vilamakitug, an antibody targeting IL-1alpha.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Veligrotug, an antibody targeting IGF-1R.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Vamikibart, an antibody targeting IL6.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Umesolerbart, an antibody targeting Bet v 1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Tulisokibart, an antibody targeting TL1A.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Suvemcitug, an antibody targeting VEGF-A.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Riliprubart, an antibody targeting C1s.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Rademikibart, an antibody targeting IL-4Ralpha.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Nisevokitug, an antibody targeting TGF-beta1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Mevonlerbart, an antibody targeting Fel d 1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Gotistobart, an antibody targeting CTLA-4.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Freneslerbart, an antibody targeting Fel d 1.